Welcome to the Cerba Research Oncology Blog, your source for cutting-edge insights into oncology clinical trials, biomarker strategies, and laboratory innovations. Cerba Research’s global experts share practical knowledge on immuno-oncology advancements, including flow cytometry, IHC, NGS, and multiplex assays to drive therapeutic success.
Why Read Our Blog
Stay ahead with real-world applications from Cerba Research’s 35+ years supporting Phase I/II oncology studies, featuring expert case studies like Ki-67 scoring and multiplex IHC panels. Gain actionable intelligence for drug development, from ADCs to immunotherapy biomarkers, tailored for clinical research professionals
